526 related articles for article (PubMed ID: 32873927)
21. Targeted and immunotherapeutic approaches in brain metastases.
Ahluwalia MS; Winkler F
Am Soc Clin Oncol Educ Book; 2015; ():67-74. PubMed ID: 25993144
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors of brain metastases from breast cancer: impact of targeted therapies.
Braccini AL; Azria D; Thezenas S; Romieu G; Ferrero JM; Jacot W
Breast; 2013 Oct; 22(5):993-8. PubMed ID: 23831232
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms and Therapy for Cancer Metastasis to the Brain.
Franchino F; Rudà R; Soffietti R
Front Oncol; 2018; 8():161. PubMed ID: 29881714
[TBL] [Abstract][Full Text] [Related]
24. Optimal management of brain metastases from breast cancer. Issues and considerations.
Bartsch R; Berghoff AS; Preusser M
CNS Drugs; 2013 Feb; 27(2):121-34. PubMed ID: 23239265
[TBL] [Abstract][Full Text] [Related]
25. Management of brain metastases in non-small cell lung cancer in the era of tyrosine kinase inhibitors.
Wrona A; Dziadziuszko R; Jassem J
Cancer Treat Rev; 2018 Dec; 71():59-67. PubMed ID: 30366200
[TBL] [Abstract][Full Text] [Related]
26. Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.
Chamberlain MC; Baik CS; Gadi VK; Bhatia S; Chow LQ
Neuro Oncol; 2017 Jan; 19(1):i1-i24. PubMed ID: 28031389
[TBL] [Abstract][Full Text] [Related]
27. Melanoma brain metastasis: overview of current management and emerging targeted therapies.
Fonkem E; Uhlmann EJ; Floyd SR; Mahadevan A; Kasper E; Eton O; Wong ET
Expert Rev Neurother; 2012 Oct; 12(10):1207-15. PubMed ID: 23082737
[TBL] [Abstract][Full Text] [Related]
28. Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.
Kotecha R; Miller JA; Venur VA; Mohammadi AM; Chao ST; Suh JH; Barnett GH; Murphy ES; Funchain P; Yu JS; Vogelbaum MA; Angelov L; Ahluwalia MS
J Neurosurg; 2018 Jul; 129(1):50-59. PubMed ID: 28799876
[TBL] [Abstract][Full Text] [Related]
29. Systemic therapy for brain metastases.
Venur VA; Karivedu V; Ahluwalia MS
Handb Clin Neurol; 2018; 149():137-153. PubMed ID: 29307351
[TBL] [Abstract][Full Text] [Related]
30. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score.
Schaule J; Kroeze SGC; Blanck O; Stera S; Kahl KH; Roeder F; Combs SE; Kaul D; Claes A; Schymalla MM; Adebahr S; Eckert F; Lohaus F; Abbasi-Senger N; Henke G; Szuecs M; Geier M; Sundahl N; Buergy D; Dummer R; Guckenberger M
Radiat Oncol; 2020 Jun; 15(1):135. PubMed ID: 32487100
[TBL] [Abstract][Full Text] [Related]
31. Systemic Therapy for Lung Cancer Brain Metastases.
Pellerino A; Bruno F; Rudà R; Soffietti R
Curr Treat Options Oncol; 2021 Oct; 22(12):110. PubMed ID: 34693454
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation.
Martin AM; Cagney DN; Catalano PJ; Alexander BM; Redig AJ; Schoenfeld JD; Aizer AA
JAMA Oncol; 2018 Aug; 4(8):1123-1124. PubMed ID: 29327059
[TBL] [Abstract][Full Text] [Related]
33. Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG).
Christodoulou C; Kalogera-Fountzila A; Karavasilis V; Kouvatseas G; Papandreou CN; Samantas E; Varaki K; Papadopoulos G; Bobos M; Rallis G; Razis E; Goudopoulou A; Kalogeras KT; Syrigos KN; Fountzilas G
J Neurooncol; 2017 Sep; 134(2):443-451. PubMed ID: 28687923
[TBL] [Abstract][Full Text] [Related]
34. Toxicity and efficacy of Gamma Knife radiosurgery for brain metastases in melanoma patients treated with immunotherapy or targeted therapy-A retrospective cohort study.
Gatterbauer B; Hirschmann D; Eberherr N; Untersteiner H; Cho A; Shaltout A; Göbl P; Fitschek F; Dorfer C; Wolfsberger S; Kasprian G; Höller C; Frischer JM
Cancer Med; 2020 Jun; 9(11):4026-4036. PubMed ID: 32249551
[TBL] [Abstract][Full Text] [Related]
35. Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema.
Carlson JA; Nooruddin Z; Rusthoven C; Elias A; Borges VF; Diamond JR; Kavanagh B; Kabos P
Neuro Oncol; 2014 Jul; 16(7):1006-9. PubMed ID: 24497407
[TBL] [Abstract][Full Text] [Related]
36. Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4.
Stumpf PK; Cittelly DM; Robin TP; Carlson JA; Stuhr KA; Contreras-Zarate MJ; Lai S; Ormond DR; Rusthoven CG; Gaspar LE; Rabinovitch R; Kavanagh BD; Liu A; Diamond JR; Kabos P; Fisher CM
Clin Cancer Res; 2019 Jul; 25(13):3946-3953. PubMed ID: 30940654
[TBL] [Abstract][Full Text] [Related]
37. Trastuzumab Emtansine (T-DM1) and stereotactic radiation in the management of HER2+ breast cancer brain metastases.
Mills MN; Walker C; Thawani C; Naz A; Figura NB; Kushchayev S; Etame A; Yu HM; Robinson TJ; Liu J; Vogelbaum MA; Forsyth PA; Czerniecki BJ; Soliman HH; Han HS; Ahmed KA
BMC Cancer; 2021 Mar; 21(1):223. PubMed ID: 33663447
[TBL] [Abstract][Full Text] [Related]
38. Melanoma brain metastases: an unmet challenge in the era of active therapy.
Gorantla V; Kirkwood JM; Tawbi HA
Curr Oncol Rep; 2013 Oct; 15(5):483-91. PubMed ID: 23954973
[TBL] [Abstract][Full Text] [Related]
39. State of affairs regarding targeted pharmacological therapy of cancers metastasized to the brain.
Steiger HJ; Vollmer K; Rogers S; Schwyzer L
Neurosurg Rev; 2022 Oct; 45(5):3119-3138. PubMed ID: 35902427
[TBL] [Abstract][Full Text] [Related]
40. Tucatinib with capecitabine and trastuzumab in advanced HER2-positive metastatic breast cancer with and without brain metastases: a non-randomised, open-label, phase 1b study.
Murthy R; Borges VF; Conlin A; Chaves J; Chamberlain M; Gray T; Vo A; Hamilton E
Lancet Oncol; 2018 Jul; 19(7):880-888. PubMed ID: 29804905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
